- Vysis FISH
- Abbott REAL-TIME PCR
- Ordering Information
For more information, contact Abbott.
ContactThe LSI MLL Dual Color, Break Apart Rearrangement Probe is intended for the detection of translocations involving the MLL gene. The probe maybe used with metaphase chromosomes or interphase nuclei.
Translocations disrupting the MLL (ALL-1,HRX) gene are among the most common cytogenetic abnormalities observed in hematopoietic malignancies. Although over 30 variant translocations have been seen involving MLL translocations, the most common abnormalities are t(4;11)(q21;q23), t(9;11) (p22;q23), and t(11;19)(q23;p13).
The LSI MLL Dual Color, Break Apart Rearrangement Probe consists of a 350 kb portion centromeric of the MLL gene breakpoint cluster region (bcr) labeled in SpectrumGreen and approximately 190 kb portion largely telomeric of the bcr labeled in SpectrumOrange. In approximately 25% of 11q23 translocations, a region beginning at the MLL breakpoint and extending distally is deleted. This probe can provide a better indication of the presence of the 11q23 translocation than a single color probe design.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.